Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3ACETYLSALICYLIC ACID

02 1ASCORBIC ACID

03 3BILASTINE

04 3BUTALBITAL

05 3CAFFEINE

06 2CODEINE PHOSPHATE

07 1DICLOFENAC POTASSIUM

08 1ISOPROPYL MYRISTATE

09 1NAPROXEN SODIUM

10 1POLYETHYLENE GLYCOL 3350

11 1POTASSIUM CHLORIDE

12 1SODIUM ASCORBATE

13 1SODIUM CHLORIDE

14 1SODIUM SULFATE ANHYDROUS

15 1SUMATRIPTAN (SUMATRIPTAN SUCCINATE)

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : FIORINAL-C 1/4

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL-C 1/4

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 330MG

Packaging : 100

Brand Name : FIORINAL-C 1/4

Approval Date :

Application Number : 176192

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

blank

02

Brand Name : FIORINAL-C 1/4

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL-C 1/4

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100

Brand Name : FIORINAL-C 1/4

Approval Date :

Application Number : 176192

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

blank

03

Brand Name : FIORINAL-C 1/2

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL-C 1/2

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 330MG

Packaging : 100/500

Brand Name : FIORINAL-C 1/2

Approval Date :

Application Number : 176206

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

blank

04

Brand Name : FIORINAL

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100

Brand Name : FIORINAL

Approval Date :

Application Number : 226327

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

blank

05

Brand Name : FIORINAL

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 330MG

Packaging : 100

Brand Name : FIORINAL

Approval Date :

Application Number : 226327

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

blank

06

Brand Name : FIORINAL-C 1/2

CPhI India 2024
Not Confirmed
arrow

Brand Name : FIORINAL-C 1/2

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Brand Name : FIORINAL-C 1/2

Approval Date :

Application Number : 176206

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

blank

07

Brand Name : BLEXTEN

CPhI India 2024
Not Confirmed
arrow

Brand Name : BLEXTEN

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : SOLUTION

Dosage Strength : 2.5MG/ML

Packaging :

Brand Name : BLEXTEN

Approval Date :

Application Number : 2519011

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Brand Name : BLEXTEN

CPhI India 2024
Not Confirmed
arrow

Brand Name : BLEXTEN

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging :

Brand Name : BLEXTEN

Approval Date :

Application Number : 2519038

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Brand Name : MOVIPREP

CPhI India 2024
Not Confirmed
arrow

Brand Name : MOVIPREP

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 4.7G/SACHET

Packaging : 1 PCK

Brand Name : MOVIPREP

Approval Date :

Application Number : 2359499

Regulatory Info : Ethical

Registration Country : Canada

blank

10

Brand Name : BLEXTEN

CPhI India 2024
Not Confirmed
arrow

Brand Name : BLEXTEN

arrow
CPhI India 2024
Not Confirmed

Aralez Pharmaceuticals

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 2/10/20/30/40/50

Brand Name : BLEXTEN

Approval Date :

Application Number : 2454130

Regulatory Info : Prescription

Registration Country : Canada

blank